Stories Library
We proudly offer support and resources to researchers, healthcare providers, patients and their advocates as well as our local communities.
June 01, 2022
It Takes a VillageResearch that led to important discoveries for the treatment of dangerously high cholesterol
Research & Preclinical Development
April 21, 2022
Striving for Impact through ResponsibilityRegeneron is committed to achieving our Global Responsibility Goals by 2025. Read the steps we're taking in the 2021 Responsibility Report.
Responsibility & Culture
December 21, 2021
Paving the Way for a Better Workplace, Better Science, and a Better WorldRegeneron’s first Chief Diversity, Equity & Inclusion (DEI) Officer, Smita Pillai, explains how leadership through action is ensuring our presence in biotech is mindful, equitable and intersectional.
Responsibility & Culture
November 09, 2021
Helping the several million immunocompromised Americans who are still “Prisoners of the Pandemic”Regeneron has received numerous queries about making our REGEN-COV® (casirivimab and imdevimab) antibody cocktail available to protect immuno­compromised individuals who do not respond to COVID19 vaccines. This blog reflects our thinking and the current scientific evidence related to this question.
Responsibility & Culture
October 01, 2021
Staying Safe through ScienceLearn about Regeneron's Environment Health & Safety (EH&S) team and how it navigates a constantly changing business environment.
Responsibility & Culture
August 01, 2021
Moving at Pandemic SpeedRapid response to infectious diseases.
Clinical Research & Medicines
July 06, 2021
A New Breakthrough in the Search for Protective Genetics – and the Medicines That Mimic ThemLearn more about protective genetic variants and the Regeneron Genetics Center's discovery of the GPR75 protective gene associated with reduced body weight and obesity risk.
Genetics
June 15, 2021
Data Privacy Is in Our DNALearn more about the importance of data privacy and how Regeneron works to safeguard personal data, including genetic data. See our Data Privacy Philosophy for more information.
Responsibility & Culture
December 02, 2020
Two Targets May Be Better Than OneRegeneron leaders Andres Sirulnik and Israel Lowy discuss why they believe bispecific antibodies may be the next class of medicines to revolutionize cancer treatment.
Clinical Research & Medicines, Research & Preclinical Development
November 22, 2020
Chatting With Young ScientistsRegeneron is committed to fostering the next generation of scientific innovators who can solve society's greatest challenges. Hear from our own research scientist as she discusses career paths in science with two winners of the 2020 Regeneron Science Talent Search.
Responsibility & Culture